Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Pharmaceutical company Moderna (MRNA) and energy provider Enbridge (ENB) are scheduled to release earnings on Friday. The US Census Bureau will report January's retail sales data, expecting a ...

HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services Department was re-evaluating its $590 million contract to develop a bird flu ...

Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...

The drugmaker also filed for approval of its combined flu and Covid vaccine, but said approval might require vaccine efficacy data from its ongoing Phase 3 seasonal flu vaccine study. Moderna did ...

according to data from the TipRanks Forecast page. Notably, Moderna missed EPS estimates only twice out of the last nine quarters. Analysts’ Views on MRNA Ahead of Q4 Results Ahead of Moderna ...

The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 vaccine sales.

The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

The court said Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that ...

Julie Hyman and Josh Lipton preview the biggest earnings stories and economic data due out tomorrow, Friday, February 14. Pharmaceutical company Moderna (MRNA) and energy provider Enbridge (ENB) are ...